Skip to main content

Table 3 Drug use (past 30 days) and risk behaviour of the drug users in Kathmandu Valley ( N= 300)

From: ‘South Asian cocktail’ - the concurrent use of opioids, benzodiazepines and antihistamines among injecting drug users in Nepal and associations with HIV risk behaviour

  No cocktail use Moderate use Intensive use Significancea (χ2, ANOVA)
Alcohol 66.7% 66.7% 60.6% χ2 = 1.2, p = .558
  Number of days 19.1 (±11.7) 22.1 (±10.0) 18.6 (±10.4) F = 2.4, p = .098
Heroin 81.4% x, y 29.4% x, z 51.0% y, z χ2 = 33.9, p < .001
  Number of days 27.0 (±7.4) x, y 13.8 (±10.6) x 16.0 (±10.2) y F = 19.5, p < .001
Cannabis 69.8% x 87.3% x 80.0% χ2 = 6.2, p < .05
  Number of days 24.8 (±9.1) 21.7 (±9.6) 24.0 (±8.1) F = 2.5, p = .088
Benzodiazepines 27.9% x, y 94.1% x 89.7% y χ2 = 103.1, p < .001
  Number of days 22.6 (±9.4) 25.0 (±8.8) 26.2 (±6.8) F = 1.7, p = .193
Chewing tobacco 25.6% y 39.2% z 52.3% y, z χ2 = 11.2, p < .01
  Number of days 23.5 (±9.1) 24.5 (±9.1) 21.3 (±9.9) F = 1.5, p = .229
Number of different substances 4.7 (±1.8) x, y 6.0 (±1.5) x 6.5 (±1.9) y F = 17.7, p < .001
Use of 10-ml syringes 11.8% x, y 61.8% x 56.9% y χ2 = 14.9, p < .001
Multiple use of the same needle 45.0% x, y 69.6% x 74.8 y χ2 = 13.3, p < .01
Needle/equipment sharing 48.8% y 61.8% z 90.3% y, z χ2 = 43.8, p < .001
N 43 102 155  
  1. aThe characters x, y and z indicate significant differences between groups according to post hoc statistical tests.